Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Staddon, A.P.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(4)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(3)
+
-
Creation Date
2012
(3)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Author
Blay, J.Y.
(4)
+
-
Chawla, S.P.
(4)
+
-
Staddon, A.P.
(4)
+
-
Aglietta, M.
(3)
+
-
Araki, N.
(3)
+
-
Beppu, Y.
(3)
+
-
Casali, P.G.
(3)
+
-
Cesne, A. le
(3)
+
-
Gelderblom, H.
(3)
+
-
Graaf, W.T.A. van der
(3)
+
-
Hohenberger, P.
(3)
+
-
Judson, I.R.
(3)
+
-
Marreaud, S.
(3)
+
-
Ouali, M.
(3)
+
-
Demetri, G.D.
(2)
+
-
Dewji, M.
(2)
+
-
Hodge, R.
(2)
+
-
Kim, D.W.
(2)
+
-
Nguyen, B.B.
(2)
+
-
Schoffski, P.
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance
Global differences in chemotherapeutic regimens of soft tissue sarcoma (STS): Results of PALETTE, an EORTC 62072/GSK VEG110727 global network phase III trial of pazopanib versus placebo
PALETTE: Final overall survival (OS) data and predictive factors for OS of EORTC 62072/GSK VEG110727, a randomized double-blind phase III trial of pazopanib versus placebo in advanced soft tissue sarcoma (STS) patients
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial